Understanding the Eye Drop Recalls of 2023
In early 2023, the FDA and CDC issued significant recalls for over-the-counter eye drops found to be non-sterile or contaminated, posing risks of severe eye infections, vision loss, and death. Three products were notably affected: EzriCare Artificial Tears, Delsam Pharma Artificial Tears, and Pharmedica USA's Purely Soothing 15% MSM Drops.
The EzriCare and Delsam Pharma Artificial Tears Recalls
Global Pharma Healthcare recalled EzriCare Artificial Tears in February 2023, followed by Delsam Pharma Artificial Tears and Ointment. These recalls were prompted by a multi-state outbreak of infections caused by a drug-resistant Pseudomonas aeruginosa. The outbreak resulted in hospitalizations, permanent vision loss, and deaths.
The Pharmedica USA Purely Soothing 15% MSM Drops Recall
Pharmedica USA recalled Purely Soothing 15% MSM Drops in March 2023 due to non-sterility concerns. The FDA warned that using non-sterile eye drops could lead to eye infections and potential blindness.
The Serious Risks of Contaminated Eye Drops
Contaminated eye drops can introduce harmful bacteria or microorganisms to the eye. Using non-sterile products can cause serious eye infections, potentially leading to irreversible vision loss. In some cases, infections can spread and be life-threatening.
Comparison of Recalled Eye Drops
A comparison of the recalled eye drops regarding manufacturer, reason for recall, and key risks is available from {Link: forthepeople.com https://www.forthepeople.com/blog/what-eye-drop-brands-are-recalled/}.
What to Do If You Have Recalled Drops
- Stop use immediately: Discontinue using any recalled eye drops or ointment.
- Dispose of the products safely: Follow manufacturer instructions for disposal or return.
- Check for symptoms: Watch for signs of eye infection (blurred vision, redness, pain, discharge, light sensitivity) and seek medical help if they appear.
- Report adverse effects: Report any issues from using recalled products to the FDA's MedWatch program.
- Talk to your healthcare provider: Consult your eye care specialist for alternative eye drop recommendations, favoring reputable brands.
- Avoid buying online from unknown sellers: Purchase eye drops from trusted retailers to avoid recalled or counterfeit products.
Conclusion
The 2023 eye drop recalls, including those for EzriCare, Delsam Pharma, and Pharmedica USA products, highlight the critical need for quality control in pharmaceuticals. Contaminated eye drops pose serious health risks. Consumers should immediately stop using recalled products and follow FDA guidance. Choosing reputable brands and staying informed are vital steps to protect eye health. For the latest information, refer to the official FDA recall website.